Evidence map›Paper›PMID 34610932›Full record

ArticleBMJ open2021

Oncology patients' experiences in experimental medicine cancer trials: a qualitative study.

Chelsea Sawyer, Laurie Preston, Sally Taylor, Michelle Davies, Louise Carter, Matthew Krebs, Natalie Cook, Donna Graham, Fiona Thistlewaite, Janelle Yorke

Abstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Reflections on the opportunities and challenges of applying experience-based co-design (EBCD) to phase 1 clinical trials in oncology.Health expectations : an international journal of public participation in health care and health policy · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chelsea SawyerChristie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UK chelsea.sawyer@nhs.net.ORCID 0000-0003-2596-1580
Laurie PrestonChristie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UK.
Sally TaylorChristie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UK.
Michelle DaviesThe Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.
Louise CarterThe Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.
Matthew KrebsThe Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.
Natalie CookThe Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.
Donna GrahamThe Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.
Fiona ThistlewaiteThe Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK.
Janelle YorkeChristie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe study aimed to explore patients' experiences of experimental cancer medicine (ECM) clinical trials.

designThe study's design was qualitative. Two focus groups with patients were undertaken followed by semistructured interviews, to explore patients' experiences of ECM clinical trials. Interviews and focus groups were audiorecorded and transcribed verbatim. Data were analysed using thematic analysis.

settingA regional cancer centre (tertiary care) in North-West England.

participantsTwelve patients (aged 52-79) participated in one of the two focus groups and 22 patients (aged 42-83) participated in interviews. PRIMARY OUTCOME MEASURE: Patients' experiences of an ECM trial.

resultsFour main themes were identified from the analysis: decision making, information needs, the experience of trial participation and impact of trial participation. Subthemes are presented in the manuscript.

conclusionTo make fully informed decisions about trial participation, patients required the simplification of trial information and wanted more information about side effects, their response to trial treatment and the overall trial progress throughout the trial. Patients highlighted the need for improvement for the support provided to their family and friends.

Indexed as

Biomedical ResearchNeoplasmsFocus GroupsHumansMedical OncologyQualitative Researchadult oncologyclinical trialsqualitative research

Identifiers

PMID34610932
PMCPMC8493921

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.